IQuity, Inc. is a data science company using genomic and proprietary healthcare datasets to detect and monitor chronic disease. At IQuity, we developed a game-changing blood test using RNA data (genomic) to accurately identify autoimmune disease earlier than current, conventional testing methodologies. The application of data science and machine learning is the core of our business and drives our technological development.
IQuity offers three blood tests to help providers diagnose multiple sclerosis, IBS/IBD-Crohn’s and ulcerative colitis, and fibromyalgia with greater than 90 percent accuracy. Disease activity and monitoring tests are currently in development with planned releases in 2018.
IQuity operates a COLA accredited, CLIA-certified laboratory in Nashville, Tennessee, USA.
Synthesis of cDNA templates using oligo-dT or random hexamer primers. RNA quality will be assessed prior to synthesis.
Custom gene expression studies per user request. Primer design services, including Sanger sequencing of PCR products can be performed. Quotes based on scope of project.
Complete RNA-sequencing services can be provided for the user. Library preparation, sequencing, and initial analyses can be performed. Consulting services beyond standard RNA-seq analysis (differential expression, library quality, etc.) based on annotated lists will be quoted based on the scope of the project.
Sanger sequencing projects will be quoted based on the scope of the project.
We provide RNA isolation services from a variety of tissues. Our process ensures maximum, high quality yields.
Isolation of genomic DNA from a variety of biological tissues. Please send information regarding sample type and expected yield to schedule a consultation.
Oligo design and validation services. Quotes based on scope of project.
Chromatin Immunoprecipitation (ChIP) Assays Services
IQuity has not received any reviews.
IQuity has not received any endorsements.